Skip to main content
SpringerLink
Log in

Proceedings of the Annual Meeting of the European Foundation for Bone Marrow Transplantation

Sils Maria (Engadine), Switzerland April 13–16, 1980

  • Published:
Blut Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Camitta BM, Thomas ED, Nathan DG, Santos G, Gordon-Smith EC, Gale RP, Rappeport JM, Storb R (1976) Severe aplastic anemia: A prospective study of the effect of early marrow transplantation on acute mortality. Blood 48: 63–70

    PubMed  CAS  Google Scholar 

  2. Gluckman E, Devergie A, Dutreix A, Dutreix J, Boiron M, Bernard J (1980) Bone marrow grafting in aplastic anemia after conditioning with Cyclophosphamide and total body irradiation with lung shielding. In: Thierfelder S, Rodt H, Kolb HJ (eds) Immunobiology of bone marrow transplantation. Springer, Berlin Heidelberg New York. pp. 339–347

    Google Scholar 

  3. Gluckman E, Devergie A, Schaison G, Bussel A, Berger R, Sohier J, Bernard J (1980) Bone marrow transplantation in Fanconi anemia. Br J Haemat (in press)

  4. Ramsay NKC, Kim T, Nesbit ME, Krivit W, Coccia PF, Levitt SH, Woods WG, Kersey JH (1980) Total lymphoid irradiation and cyclophosphamide as preparation for bone marrow transplantation in severe aplastic anemia. Blood 55: 344–346

    PubMed  CAS  Google Scholar 

  5. Santos GW, Sensenbrenner LL, Burke PJ, Mullins GM, Anderson PN, Tutschka P, Braine HG, Davis TE, Humphrey RL, Abeloff MD, Bias WB, Borgaonkar DS, Slavin RE (1974) Allogeneic marrow grafts in man using cyclophosphamide. Transplant Proc 6: 345–448

    PubMed  CAS  Google Scholar 

  6. Storb R, Thomas ED, Buckner CD, Clift RA, Johnson FL, Fefer A, Glucksberg H, Giblett ER, Lerner KG, Neiman PE (1974) Allogeneic marrow grafting for treatment of aplastic anemia. Blood 43: 157–180

    PubMed  CAS  Google Scholar 

  7. Storb R (for the Seattle Marrow Transplant team) (1979) Decreasse in the graft rejection rate and improvement in survival after marrow transplantation for severe aplastic anemia. Transplant Proc 11: 196–198

    PubMed  CAS  Google Scholar 

  8. Storb R, Thomas ED, Buckner CD, Clift RA, Deeg HJ, Fefer A, Goodell BW, Sale GE, Sanders JE, Singer J, Stewart P, Weiden PL (1980) Marrow transplantation in 30 untransfused patients with severe aplastic anemia. Ann Int Med 92: 30–36

    PubMed  CAS  Google Scholar 

References

  1. Berger R, Bernheim A, Gluckman E, Gisselbrecht (1980) In vitro effect of cyclophosphamide metabolites on chromosomes of Fanconi anemia patients. Br J Haematol (in press)

  2. Camitta BM, Thomas ED, Nathan DG, Santos G, Gordon-Smith EC, Gale RP, Rappeport JM, Storb R (1976) Severe aplastic anemia: A prospective study of the effect of early marrow transplantation on acute mortality. Blood 48: 63–70

    PubMed  CAS  Google Scholar 

  3. Gluckman E, Devergie A, Marty M, Bussel A, Rottembourg J, Dausset J, Bernard J (1978) Allogenic bone marrow transplantation in aplastic anemia. Report of 25 cases. Transplant Proc 10: 141–146

    PubMed  CAS  Google Scholar 

  4. Gluckman E, Devergie A, Dutreix A, Dutreix J, Boiton M, Bernard J (1980) Bone marrow grafting in aplastic anemia after conditionning with cyclophosphamide and total body irradiation with lung shielding. In: Thierfelder S, Rodt H, Kolb HJ (eds) Immunobiology of bone marrow transplantation. Springer, Berlin Heidelberg New York, pp 339–347

    Google Scholar 

  5. Gluckman E, Devergie A, Schaison G, Bussel A, Berger R, Sohier J, Bernard J (1980) Bone marrow transplantation in Fanconi anemia. Br J Haematol (in press)

  6. Powles RI, Clink HM, Spence D, Morgenstein G, Watson JG, Selby PJ, Woods M, Barrett A, Jameson B, Sloane J, Lawler SO, Kay HEM, Lawson D, Mc Elwain TJ, Alexander P (1980) Cyclosporin-A to prevent graft versus host disease in men after allogenic bone marrow transplant. Lancet 1: 327–329

    Article  PubMed  CAS  Google Scholar 

  7. Santos GW, Sensenbrenner LL, Burke PJ, Mullins GM, Anderson PN, Totschka P, Braine HG, Davis TE, Humphrey RL, Abeloff MD, Bias WB, Borgaonkar DS, Slavin RE (1974) Allogenic marrow grafts in man using cyclophosphamide. Transplant Proc 6: 345–348

    PubMed  CAS  Google Scholar 

  8. Sensenbrenner LL, Steele AA, Santos GW (1977) Recovery of hematologic competence without engraftment following attempted bone marrow transplantation in a patient with severe aplastic anemia. Exp Hematol 5: 51–55

    PubMed  CAS  Google Scholar 

  9. Speck B, Cornu P, Jeannet M, Nissen C, Burri HP, Groff P, Nagel GA, Buckner CD (1976) Antologous marrow recovery following allogenic marrow transplantation in a patient with aplastic anemia. Exp Hematol 4: 131–137

    PubMed  CAS  Google Scholar 

  10. Storb R, Thomas ED, Buckner CD, Clift RA, Johnson FL, Fefer A, Glucksberg H, Giblett ER, Lerner KG, Neiman PE (1974) Allogenic marrow grafting for treatment of aplastic anemia. Blood 43: 157–180

    PubMed  CAS  Google Scholar 

  11. Storb R (for the Seattle Marrow Transplant Team) (1979) Decrease in the graft rejection rate and improvement in survival after marrow transplantation for severe aplastic anemia. Transplant Proc 11: 196–198

    PubMed  CAS  Google Scholar 

  12. Storb R, Thomas ED, Buckner CD, Clift RA, Deeg HJ, Fefer A, Goodell BW, Sale GE, Sanders JE, Singer J, Stewart P, Weiden PL (1980) Marrow transplantation in 30 untransfused patients with severe aplastic anemia. Ann Int Med 92: 30–36

    PubMed  CAS  Google Scholar 

  13. Thomas ED, Storb R, Giblett ER, Lonpre B, Weiden PL, Fefer A, Witherspoon R, Clift RA, Buckner CD (1976) Recovery from aplastic anemia following attempted marrow transplantation. Exp Haematol 4: 97–102

    CAS  Google Scholar 

References

  1. Speck B, Buckner CD, Cornu P, Jeannet M (1976) Rationale for the use of ALG as sole immunosuppressant in allogenetic bone marrow transplantation for aplastic anemia. Transplant Proc 8: 617–622

    PubMed  CAS  Google Scholar 

  2. Speck B, Gluckman E, Haak HL, van Rood JJ (1977) Treatment of aplastic anaemia by antilymphocyteglobulin with and without allogenetic bone marrow infusions. Lancet 2: 1145–1148

    Article  PubMed  CAS  Google Scholar 

  3. Speck B, Cornu P, Nissen C, Groff P, Weber W, Jeannet M (1978) On the pathogenesis and treatment of applastic anemia. Exp Hematol Today 2: 143–149

    Google Scholar 

  4. Nissen C, Cornu P, Gratwohl A, Speck B (1980) Peripheral blood cells from patients with aplastic anaemia in partial remission suppress growth of their own bone marrow precursors in culture. Br J Haematol (in press)

References

  1. Camitta BM, Thomas ED (1978) Severe aplastic anaemia: A prospective study of the effect of androgens or transplantation on haematological recovery and survival. Clin Haematol 7: 587–595

    PubMed  CAS  Google Scholar 

  2. Fenyk Jr JR, Smith CM, Warkentin PI, Krivit W, Golt RW, Neely JE, Nesbit ME, Ramsay NKC, Coccia PF, Kersey JH (1978) Sclerodermatous graft-versus-host disease limited to an area of measles exanthem. Lancet 1: 472–473

    Article  PubMed  Google Scholar 

  3. Gale RP (for the UCLA Bone Marrow Transplant Team) (1978) The role of cyclophosphamide and total-body irradiation in marrow transplantation for severe aplastic anemia. In: Baum SJ, Ledney GD (eds) Experimental hematology today. Springer, New York. pp 157–162

    Google Scholar 

  4. Guiot HFL, Furth van R (1977) Partial antibiotic decontamination. Br Med J 1: 800–802

    CAS  PubMed  Google Scholar 

  5. Kersey JH (1980) Meeting on TLI in organ transplantation. Stanford University, April 1980

  6. Kersey JH, Krivit W, Nesbit ME, Ramsay NKC, Coccia PF, Levitt SH, Kim TH (1979) Combined cyclophosphamide—total lymphoid irradiation compared to other forms of immunosuppression for human marrow transplantation. In: Baum SJ, Ledney GD (eds) Experimental hematology today. Springer, New York. pp 179–184

    Google Scholar 

  7. Selby PJ, Powles RL, Jameson B, Kay HEM, Watson JG, Thornton R, Morgenstern G, Clink HM, McElwain TJ, Prentice HG, Corringham R, Ross MG, Hoffbrand AV, Brigden D (1979) Parenteral acyclovir therapy for herpesvirus infections in man. Lancet 2, 1267–1270

    Article  PubMed  CAS  Google Scholar 

  8. Slavin S, Fuks Z, Kaplan HS, Strober S (1978) Transplantation of allogenetic bone marrow without graft-versus-host disease, using total lymphoid irradiation. J Exp Med 147: 963–972

    Article  PubMed  CAS  Google Scholar 

  9. Slavin S, Gottlieb M, Strober S, Bieber C, Hoppe R, Kaplan HS, Grumet FC (1979) Transplantation of bone marrow in outbred dogs without graft-versus-host disease, using total lymphoid irradiation. Transplantation 27: 139–142

    PubMed  CAS  Google Scholar 

  10. Storb R, Prentice RL, Thomas ED (1977) Marrow transplantation for treatment of aplastic anaemia. An analysis of factors associated with graft rejection. New Engl J Med 296: 61–66

    Article  PubMed  CAS  Google Scholar 

  11. Storb R, Thomas ED, Weiden PL, Buckner CD, Clift RA, Fefer A, Goodell BW, Johnson FL, Neiman PE, Sanders JE, Singer J (1978) One-hundred-ten patients with aplastic anemia (AA) treated by marrow transplantation in Seattle. Transplant Proc 10: 135–140

    PubMed  CAS  Google Scholar 

  12. Thomas ED, Storb R, Clift RA, Fefer A, Johnson FL, Neiman PE, Lerner KG, Glucksberg H, Buckner CD (1975) Bone marrow transplantation. New Engl J Med 292: 832–843, and 895–902

    Article  PubMed  CAS  Google Scholar 

  13. Tricot GJK, Zwaan FE, Kauffmann RH, Jansen J, Haak HL (1980) Extreme potassium loss in a patient with severe graft-versus-host disease. (Submitted for publication)

  14. Zarrabi MH, Rosner F, Bennett JM (1979) Non-Hodgkin's lymphoma and acute myeloblastic leukemia. A report of 12 cases and review of the literature. Cancer 44: 1070–1080

    Article  PubMed  CAS  Google Scholar 

References

  1. Bacigalupo A, Podesta' M, van Lint MT, Marmont AM (1980) Lack of in vitro colony (CFU-c) formation and myelosuppressive activity in patients with severe aplastic anemia, after complete autologous hematologic reconstitution. Exp Hematol (in press)

  2. Bolton WK, Couser WC (1979) Intravenous pulse methylprednisolone therapy of acute crescentic rapidly progressive glomerulonephritis. Am J Med 66: 495–498

    Article  PubMed  CAS  Google Scholar 

  3. Camitta BM, Thomas ED (1978) Severe aplastic anemia: A prospective study on the effect of androgens or transplantation on hematology recovery and survival. Clin Hematol 7: 587–590

    CAS  Google Scholar 

  4. Cleigh JS, Stenzel KH, Riggio RR (1975) Effects of intravenous methylprednisolone on mixed lymphocyte cultures in normal humans. Transplant Proc 7: 31–33

    Google Scholar 

  5. Cole BR, Brocklebank JT, Kienstra AR (1976) Pulse methylprednisolone therapy in the treatment of severe glomeruloneihritis. J Pediatr 88: 307–309

    Article  PubMed  CAS  Google Scholar 

  6. Kagan WA, Ascensao JL, Fialk MA, Coleman M, Valera EB, Good RA (1979) Studies on the pathogenesis of severe aplastic anemia. Am J Med 66: 444–448

    Article  PubMed  CAS  Google Scholar 

  7. Marmont AM, van Lint MT, Avanzi G, Adami R, Solda' A, Strada P, Barbanti M, Mingari MC, Soro O, Grazi G, Pedulla' D, Cerri R, Vitale V, Bacigalupo A (1979) Bone marrow transplantation for severe aplastic anemia. Acta Haematol 62: 121–125

    PubMed  CAS  Google Scholar 

  8. Novak E (1970) Effects of a single large intravenous dose of methylprednisolone sodium succinate. Clin Pharmacol Ther 11: 711–713

    PubMed  CAS  Google Scholar 

  9. Speck B, Gluckman E, Haak HL, van Rood JJ (1977) Treatment of aplastic anemia by antilymphocytic globulin with and without bone marrow infusion. Lancet 2, 1145–1148

    Article  PubMed  CAS  Google Scholar 

  10. Speck B, Cornu P, Nissen C, Groff P, Weber W, Jeannet M (1978) On the pathogenesis and treatment of severe aplastic anemia. In: Baum SJ, Ledney GD (eds) Experimental hematology today. Springer, Berlin Heidelberg New York. p. 143

    Google Scholar 

  11. Storb R, Prentice RL, Thomas ED (1977) Treatment of aplastic anemia by marrow transplantation from HLA identical siblings: Prognostic factors associated with graft versus host disease and survival. J Clin Invest 59: 625–630

    Article  PubMed  CAS  Google Scholar 

  12. Storb R (1979) Decrease in the graft rejection rate and improvement in survival after marrow transplantation for severe aplastic anemia. Transplant Proc 9: 196–198

    Google Scholar 

  13. Woods JE, Anderson CF, de Weerd JH, Johnson WJ, Donadio VJ, Learly FL Frohnert PP (1973) High dosage intravenously administered methylprednisolone in renal transplantation: A preliminary report. JAMA 223: 896–899

    Article  PubMed  CAS  Google Scholar 

References

  1. Amare M, Abdou NL, Cook JD, Abdou NI (1977) Aplastic anemia associated with bone marrow suppressor T cell hyper activity. Successful treatment with anti-thymocyte globulin. Clin Res 25: 333 [Abstr]

    Google Scholar 

  2. Ascensao J, Kagan W, Moore M, Pahwa R, Hansen J, Good RA (1976) Aplastic anemia. Evidence for an immunological mechanism. Lancet 1: 669–671

    Article  PubMed  CAS  Google Scholar 

  3. Baran DT, Griner PF, Klemperer MR (1976) Recovery from aplastic anemia after treatment with cyclophosphamide. N Engl J Med 295: 1522–1523

    Article  PubMed  CAS  Google Scholar 

  4. Bukowski RM, Hewlett JS, Hoffmann GC, Rothman Hamburger SA (1978) Anti-thymocyte globulin therapy of severe aplastic anemia. Blood Suppl 5 52: 1–77 [Abstr]

    Google Scholar 

  5. Gluckman E, Devergie A, Barrett AJ, Faille A, Bernard J (1977) Stimulation des cellules souches hématopoiétiques par le sérum antilymphocytaire. CR Acad Sci Paris 285 D: 841–843

    CAS  Google Scholar 

  6. Gluckman E, Devergie A, Faille A, Barrett AJ, Bonneau M, Boiron M, Bernard J (1978) Treatment of severe aplastic anemia with anti-lymphocyte globulin and androgens. Exp Hematol 6: 679–687

    PubMed  CAS  Google Scholar 

  7. GluckmanE, Devergie A, Marty M, Bussel A, Rottembourg J, Dausset J, Bernard J (1978) Allogeneic bone marrow transplantation in aplastic anemia. Report of 25 cases. Transplant Proc 10: 141–145

    PubMed  CAS  Google Scholar 

  8. Gluckman E, Devergie A, Dutreix A, Dutreix J, Boiron M, Bernard J (1980) Bone marrow grafting in aplastic anemia after conditioning with cyclophosphamide and total body irradiation with lung shielding. In: Thierfelder S, Rodt H, Kolb HJ (eds) Haematology and blood transfusion. Immunobiology of bone marrow transplantation. Springer Berlin Heidelberg New York, pp 339–347

    Google Scholar 

  9. Kagan W, Ascensao J, Pahwa R, Hansen JA, Goldstein G, Valera LB, Inlefy GS, Moore MAS, Good RA (1976) Aplastic anemia. Presence in human bone marrow of cells that suppress myelopoiesis. Proc Nat Acad Sc USA 76: 2890–2894

    Article  Google Scholar 

  10. Knospe WH, Crosby WH (1971) Aplastic anemia: A disorder of the bone marrow sinusoidal microcirculation rather than stem cell failure? Lancet: 20–22

  11. Mathe G, Amiel JL, Schwarzenberg L, Choay J, Trolard P, Schneider M, Hayat M, Schlumberger JR, Jasmin C (1970) Bone marrow graft in man after conditioning by antilymphocyte serum. Br Med J 2: 131–136

    PubMed  CAS  Google Scholar 

  12. Mathe G, Schwarzenberg L (1976) Treatment of bone marrow aplasia by bone marrow graft after conditioning with anti-lymphocyte globulin. Long term results. Exp Hematol 4: 256–264

    PubMed  CAS  Google Scholar 

  13. Pedersen J, Bjergaard EP, Nissen NJ (1978) Severe aplastic anemia with complete autologous marrow reconstitution following treatment with anti-thymocyte globulin. Scand J Haematol 21: 14–18

    Article  Google Scholar 

  14. Sensenbrenner LL, Steele AA, Santos GW (1977) Recovery of hematologic competence without engraftment following attempted bone marrow transplantation for aplastic anemia. A report of a case with diffusion chamber studies. Exp Hematol 5: 51–58

    PubMed  CAS  Google Scholar 

  15. Speck B, Buckner CB, Cornu P, Jeannet M (1976) Rationale for the use of ALG as sole immunosuppressant in allogeneic bone marrow transplantation for aplastic anemia. Transplant Proc 8: 617–622

    PubMed  CAS  Google Scholar 

  16. Speck B, Cornu P, Jeannet M, Nissen C, Burri HP, Groff P, Nagel GA, Buckner CD (1976) Autologous marrow recovery following allogeneic marrow transplantation in a patient with severe aplastic anemia. Exp Hematol 4: 131–137

    PubMed  CAS  Google Scholar 

  17. Speck B, Gluckman E, Haak HL, van Rood JJ (1977) Treatment of aplastic anemia by antilymphocyte globulin with and without allogeneic bone marrow infusion. Lancet 2: 1145–1148

    Article  PubMed  CAS  Google Scholar 

  18. Storb R, Thomas ED, Buckner CD, Clift RA, Deeg HJ, Fefer A, Goodell BW, Sale GE, Sanders JE, Singer J, Stewart P, Weiden PL (1980) Marrow transplantation in 30 untransfused patients with severe aplastic anemia. Ann Int Med 92: 30–36

    PubMed  CAS  Google Scholar 

  19. Territo MC (1977) Autologous bone marrow repopulation following high dose cyclophosphamide and allogeneic marrow transplantation in aplastic anemia. Br J Haematol 36: 305–312

    PubMed  CAS  Google Scholar 

  20. Thomas ED, Fefer A, Buckner CD, Storb R (1977) Current status of bone marrow transplantation for aplastic anemia and acute leukemia. Blood 49: 671–681

    PubMed  CAS  Google Scholar 

  21. Thomas ED (1979) Current status of marrow transplantation for aplastic anemia and acute leukemia. Am J Pathol 72: 887–892

    CAS  Google Scholar 

  22. Thomas ED, Storb R, Giblett ER, Longpre B, Weiden PL, Fefer A, Witherspoon R, Clift RA, Buckner CD (1976) Recovery from aplastic anaemia following attempted marrow transplantation. Exp Hematol 4: 97–102

    PubMed  CAS  Google Scholar 

  23. Torok Storb B, Sieff C, Storb R, Adamson JW (1978) Immune mediated aplastic anemia. Normal erythroid burst formation in two patients after T cell depletion of peripheral blood cells. Blood Suppl 5 52: 1–216 [Abstr]

    Google Scholar 

References

  1. Powles RL, Clink H, Sloane J, Barrett AJ, Kay HEM, McElwain TJ (1978) Cyclosporin A for the treatment of Graft-versus-Host disease in man. Lancet 2: 1327–1331

    Article  PubMed  CAS  Google Scholar 

  2. Powles RL, Clink HM, Spence D, Morgenstern G, Watson JG, Selby PJ, Woods M, Barrett A, Jameson B, Sloane J, Lawlor SD, Kay HEM, Lawson D, McElwain TJ, Alexander P (1980) Cyclosporin A to prevent Graft-versus-Host disease in man after allogeneic bone marrow transplantation. Lancet 1: 327–329

    Article  PubMed  CAS  Google Scholar 

  3. Storb R, Weiden PL, Thomas ED (1976) Use of antithymocyte serum in clinical and experimental marrow transplantation. Postgrad Med J [Suppl 5] 52: 96–102

    PubMed  CAS  Google Scholar 

  4. Thomas ED, Storb R, Clift RA, Fefer A, Johnson L, Neiman PE, Lerner KG, Glucksberg H, Buckner CD (1975) Bone marrow transplantation. New Engl J Med 292: 895–902

    Article  PubMed  CAS  Google Scholar 

  5. Weiden PL, Doney K, Storb R, Thomas ED (1979) Antithymocyte globulin (ATG) in human marrow transplantation. Exp Hematol 7: 102

    Google Scholar 

  6. Prentice HG, Russell NH, Bradstock KF, Lee NLY, Ganeshaguru K, Hoffbrand AV (1980) Failure of pre-incubation of donor bone marrow with specific ADA inhibitor (DCF) to prevent Graft-versus-Host disease. EBMT, Sils Maria, April 13–16, 1980

References

  1. Powles RL, Barrett AJ, Clink H, Kay HEM, et al. (1978) Cyclosporin A for the treatment of graft-versus-host disease in man. Lancet II: 1327–1331

    Article  Google Scholar 

  2. Powles RL, Clink H, Spence D, Morgenstern G et al. (1980) Cyclosporin A to prevent Graft-versus-Host Disease in man after allogeneic bone marrow transplantation. Lancet I: 327–329

    Article  Google Scholar 

References

  1. Tutschka PJ (1979) Cyclosporin-A a new outlook for immunosuppression in clinical transplantation. Blut 39: 81–87

    Article  PubMed  CAS  Google Scholar 

  2. Powles RL, Clink HM, Spence D, Morgenstern G, Watson JG, Selbyn PJ, Woods M, Barrett A, Jameson B, Sloane J, Lawler SD, Kay HE, Lawson D, McElwain TJ, Alexander P (1980) Cyclosporin-A to prevent Graft-versus-Host Disease in man after allogeneic bone marrow transplantation. Lancet I: 327–329

    Article  Google Scholar 

  3. Powles RL, Barrett A, Clink HM, Kay HE, Sloane J, McElwain TJ (1978) Cyclosporin-A for the treatment of Graft-versus-Host Disease in man. Lancet II: 1327–1331

    Article  Google Scholar 

  4. Tutschka PJ, Beschorner WE, Allison AC, Burns WN, Santos GW (1979) Use of Cyclosporin-A in allogeneic bone marrow transplantation in the rat. Nature 280: 148–151

    Article  PubMed  CAS  Google Scholar 

  5. Borel JL, Feurer C, Gubler HU, Stähelin H (1976) Biological effects of Cyclosporin-A: a new antilymphocytic agent. Agents Actions 6: 468–476

    Article  PubMed  CAS  Google Scholar 

  6. Thomas ED, Buckner CD, Clift RA, Fefer A, Johnson FL, Neiman PE, Sale GE, Sanders JW, Singer JW, Shulman H, Storb R, Weiden PL (1979) Marrow transplantation for acute non-lymphoblastic leukemia in 1. remission. N Engl J Med 301: 597–599

    Article  PubMed  CAS  Google Scholar 

  7. Marbet U, Graf U, Mihatsch MJ, Gratwohl A, Müller W, Thiel G (1980) Renale Nebenwirkungen der Therapie mit Cyclosporin-A bei der chronischen Polyarthritis und der Knochenmarktransplantation. Schweiz Med Wochenschr (in press)

  8. Speck B, Gratwohl A, Nissen C, Ruggero D, Cornu P, Burri HP, Jeannet M, (1980) Severe aplastic anemia: a prospective study on the value of different therapeutic approaches in 37 successive patients. Blut 41: 160–163

    Google Scholar 

References

  1. Borel YF (1976) Comparative study of in vitro and in vivo drug effects on cell-mediated toxicity. Immunology 31: 631–641

    PubMed  CAS  Google Scholar 

  2. Borel JF, Feurer C, Gubler HU, Stahelin H (1976) Biological effects of Cyclosporin A: a new anti-lymphocytic agent. Agents Actions 6: 468–475

    Article  PubMed  CAS  Google Scholar 

  3. Borel JF, Feurer C, Magnee C, Stahelin H (1976) Effects of the new antilymphocytic peptide Cyclosporin A in animals. Immunology 32: 1017–1025

    Google Scholar 

  4. Calne RY, Rolles K, Thiru S, McMaster P, Craddock GN, Aziz S, White DJG, Evans DB, Dunn DC, Henderson RG, Lewis P, (1979) Cyclosporin A initially as the only immuno-suppressant in 34 recipients of cadaveric organs: 32 kidneys, 2 pancreases and 2 livers. Lancet I: 1033–1036

    Article  Google Scholar 

  5. Calne RY, White DJG, Pentlow BD, Rolles K, Syrakos T, Ohtawa T, Smith DP, McMaster P, Evans DB, Herbertson BM, Thirus S (1979) Cyclosporin A = Preliminary observations in dogs with pancreatic duodenal allografts and patients with cadaveric renal transplants. Transplant Proc 11: 860–864

    PubMed  CAS  Google Scholar 

  6. Calne RY, Rolles K, White DJG, Smith DP, Herbertson BM (1978) Prolonged survival of pig orthotopic heart grafts treated with Cyclosporin A. Lancet I: 1183–1185

    Article  Google Scholar 

  7. Deeg HJ, Storb R, Gerhard-Miller L, Shulman HM, Weiden PL, Thomas ED (1980) Cyclosporin A, a powerful immunosuppressant in vivo and in vitro in the dog, fails to induce tolerance. Transplantation 29: 230–235

    PubMed  CAS  Google Scholar 

  8. Dunn DC, White DJG, Herbertson BM, Wade J (1979) Prolongation of kidney survival during and after Cyclosporin A Therapy. Transplantation 27: 359–361

    PubMed  CAS  Google Scholar 

  9. Gluckman E, Devergie A, Marty M, Bussel A, Rottembourg J, Dausset J, Bernard J (1978) Allogeneic bone marrow transplantation in aplastic anemia. Report of 25 cases. Transplant Proc 10: 141–146

    PubMed  CAS  Google Scholar 

  10. Gluckman E, Devergie A, Dutreix A, Dutreix J, Boiron M, Bernard J (1980) Bone marrow grafting in aplastic anemia after conditioning with Cyclophosphamide and total body irradiation with lung shielding. In: Thierfelder S, Rodt H, Kolb HJ (eds) Immunobiology of bone marrow transplantation. Springer, Berlin Heidelberg New York, pp 339–347

    Google Scholar 

  11. Gordon MY, Singer JW (1979) Selective effects of Cyclosporin A on colony forming lymphoïd cells in men. Nature 279: 410–411

    Article  Google Scholar 

  12. Green CJ, Allison AC, Precious S (1979) Induction of specific tolerance in rabbits by kidney allografting and short periods of Cyclosporin A treatment. Lancet II: 123–125

    Article  Google Scholar 

  13. Marwick JR, Hobbs JR, Chambers JD, Pegrum GD (1979) Timing of Cyclosporin A therapy for abrogation of HVG and GVH responses in rats. Lancet II: 1037–1039

    Article  Google Scholar 

  14. Powles R, Clink HM, Spence D, Morgenstern G, Watson JG, Selby PJ, Woods M, Barrett A, Jameson B, Sloane J, Lawler SD, Kay HEM, Lawson D, McElwain TJ Alexander P, (1980) Cyclosporin A to prevent graft versus host disease in man after allogeneic bone marrow transplant. Lancet I: 327–329

    Article  Google Scholar 

  15. Tutschka PJ, Beschorner WE, Allison AC, Burns WH, Santos GW (1979) Use of Cyclosporin A in allogeneic bone marrow transplantation in the rat. Nature 280: 148–151

    Article  PubMed  CAS  Google Scholar 

  16. White DJG, Calne RY, Plumb A (1979) Mode of action of Cyclosporin A: a new immuno-suppressive agent. Transplant Proc 11: 855–859

    PubMed  CAS  Google Scholar 

References

  1. Copenhagen Study Group of Immunodeficiencies (1973) Bone—marrow transplantation from an HL-A non—identical but mixed-lymphocyte-culture indentical donor. Lancet I: 1146–1150

    Google Scholar 

  2. Griscelli C, Durandy A, Virelizier JL, Buriot D (1979) Transplantation of lymphoid cells in patients with severe combined immunodeficiency. Meeting of the European Society for Bone marrow Transplantation, April 1979

  3. Hansen GS, Dupont B, Faber V, Jakobsen BK, Juhl F, Nielsen LS, Svejgaard A, Thomsen M, Wiik A (1977) Lymphocyte chimerism after bone marrow transplantation. Scand J Immunol 6: 299–303

    Article  PubMed  CAS  Google Scholar 

  4. Kenny AB, Hitzig WH (1979) Bone marrow transplantation for severe combined immunodeficiency disease. Eur J Pediatr 131: 155–177

    Article  PubMed  CAS  Google Scholar 

  5. Niethammer D, Goldmann SF, Haas RJ, Dietrich M, Flad H-D, Fliedner TM, Kleihauer E (1976) Bone marrow transplantation for severe combined immunodeficiency with the HL-A-A-incompatible but MLC-identical mother as donor. Transplant Proc 8: 623–628

    Google Scholar 

  6. Ramsøe K, Skinhøj P, Andersen V, Ernst P, Faber V, Platz P, Thomsen M, Svejgaard A, Riewert Eriksen K, Plesner T, Morling N, Philip J, Kiilmann S-Aa, Koch C, Muller-Berat N, Henningsen K, Axelsen NH (1978) Successful nonsibling bone marrow transplantation in severe combined immunodeficiency, Transplantation 26: 369–372

    PubMed  Google Scholar 

  7. Touraine J-L (1979) Cooperation between thymus and transplanted precursor cells during reconstitution of immunodeficiencies with bone marrow or fetal liver cells. Meeting of the European Society for Bone marrow Transplantation, April 1979

References

  1. Beutler E (1979) Nature's transplant in Fabry's disease. Lancet II: 199

    Article  Google Scholar 

  2. Buhler FR, Thiel G, Duback UE, Enderlin F, Gloor F, Tholen H (1973) Kidney transplantation in Fabry's disease. Br Med J 3: 28–29

    PubMed  CAS  Google Scholar 

  3. Clarke JTR, Guttman RD, Wolfe LS, Beaudoin JG, Morehouse DD (1972) Enzyme replacement therapy by renal allotransplantation in Fabry's disease. N Engl J Med 287: 1215–1218

    Article  PubMed  CAS  Google Scholar 

  4. Dawson G, Matalon R, Liy T (1973) Correction of the enzymic defect in cultured fibroblasts from patients with Fabry's disease. Treatment with purified galactosidase from Ficin. Pediatr Res 7: 684–690

    PubMed  CAS  Google Scholar 

  5. Desnick RJ, Simmons RL, Allen KY, Wood JE, Anderson CF, Najarian JS, Krivit W (1972) Correction of enzymatic deficiencies by renal transplantation. Surgery 72: 203–211

    PubMed  CAS  Google Scholar 

  6. Grunfeld JP, Le Porrier M, Droz D, Bensaude J, Hinglais N, Crosnier J (1975) La transplantation rénale chez les sujets atteints de maladie de Fabry. Nouv Presse Méd 4: 2081–2085

    PubMed  CAS  Google Scholar 

  7. Krivit W, Desnick RJ, Bernlohr RW, Wold F (1972) Enzyme transplantation in Fabry's disease. N Engl J Med 287: 1248–1249

    Article  PubMed  CAS  Google Scholar 

  8. Malik MC (1977) Maladie de Fabry—Tentative de traitement par greffe de foie foetal. A propos d'un cas. Thèse Médecine Lyon

  9. Philippart M, Franklin SS, Cordon A (1972) Reversal of an inborn sphingolipidosis by kidney transplantation. Ann Intern Med 77: 195–200

    PubMed  CAS  Google Scholar 

  10. Schram AW, Hamers MN, Tager JM (1977) The identity of galactosidase B from human liver. Biochim Biophys Acta 482: 138–144

    PubMed  CAS  Google Scholar 

  11. Simons RL, Desnick RT, Najarian JS, Krivit W (1973) Renal Transplantation in Fabry's disease. Cours International de Transplantation. Simep Editions, pp 59–71

  12. Spence MW, Mac Kinnon KE, Burgess JK, D'Entremont DM, Belitsky P, Lannon SG, Mac Dunald AJ (1976) Failure to correct the metabolic defect by renal allotransplantation in Fabry's disease. Ann Intern Med 84: 13–16

    PubMed  CAS  Google Scholar 

  13. Touraine JL, Malik MC, Perrot H, Maire Revillard JP, Grosshans E, Traeger J (1979) Maladie de Fabry: deux malades améliorés par la greffe de cellules de foie foetal. Nouv Presse Méd 8: 1499–1503

    PubMed  CAS  Google Scholar 

  14. Touraine JL, Malik MC, Perrot H, Maire I, Traeger J (1979) Attempt at enzyme replacement by fetal liver transplantation in Fabry's disease. Lancet 8125: 1094–1095

    Article  Google Scholar 

  15. Van den Bergh F, Rietra P, Kolk-Vegter A, Bosch E, Tager JM (1976) Therapeutic complications of renal transplantation in a patient with Fabry's disease. Acta Med Scand 200: 1248–1249

    Google Scholar 

References

  1. Bortin MM, Saltzstein EC (1969) Graft-versus-host inhibition: Fetal liver and thymus cells to minimize secondary disease. Science 164: 316–318

    PubMed  CAS  Google Scholar 

  2. Bortin NM, Rimm AA (1977) Severe combined immunodeficiency disease: characterization of the disease and results of transplantation. J Am Med Assoc 238: 591

    Article  CAS  Google Scholar 

  3. Hong R, Santosham M, Schulte-Wissermann H, Horowitz S, Hsu SH, Winkelstein JA (1976) Reconstitution of B- and T-lymphocyte function in severe combined immunodeficiency disease after transplantation with thymic epithelium. Lancet II: 1270–1272

    Article  Google Scholar 

  4. Nezelof C, Jammet ML, Lortholary P, Labrune B, Lamy M (1964) L'hypoplasie héréditaire du thymus. Sa place et sa responsabilité dans une observation d'aplasie lymphocytaire normoplasmocytaire et normoglobulinémique du nourrisson. Arch Fr Pédiatr 21: 897–920

    PubMed  CAS  Google Scholar 

  5. Pahwa R, Pahwa S, Good RA, Incefy GS, O'Reilly RJ (1977) Rationale for combined use of fetal liver and thymus for immunological reconstitution in patients with variants of severe combined immunodeficiency. Proc Natl Acad Sci 74: 3002–3005

    Article  PubMed  CAS  Google Scholar 

  6. Touraine JL (1979) Human T-lymphocyte differentiation in immunodeficiency diseases and after reconstitution by bone marrow or fetal thymus transplantation. Clin Immunol Immunopathol 12: 228–237

    Article  PubMed  CAS  Google Scholar 

  7. Touraine JL (1980) Value of alpha-fetoprotein determinations in the monitoring of patients with a fetal liver transplant for Fabry's disease or immunodeficiency. Proc First Symposium on Fetal Liver Transplantation. Excerpta Medica, Amsterdam (in press)

  8. Touraine JL (1979) Heterogeneity and pathophysiology of severe combined immunodeficiency diseases. In: Touraine JL (ed) Bone Marrow Transplantation in Europe. Excerpta Medica. Amsterdam, pp 111–116

    Google Scholar 

  9. Zinkernagel RM (1978) The thymus: Its influence on recognition of “self major histocompatibility antigens” by T cells and consequences for reconstitution of immunodeficiency. Springer Semin Immunopathol 1: 405

    Article  Google Scholar 

References

  1. Betuel H, Camoun M, Colobani J, Day NE, Ellouz R, De The G (1975) The relationship between nasopharyngeal carcinoma and the HLA system among Tunisians. Int J Cancer 16: 249

    PubMed  CAS  Google Scholar 

  2. Betuel H, Touraine JL, Souillet G, Jeune M (1978) Absence of cell-membrane HLA antigens in an immunodeficient child. Tissue Antigens 11: 68–70

    PubMed  CAS  Google Scholar 

  3. Meuwissen HJ, Pickering RJ, Pollara B, Porter IH (1975) Combined immunodeficiency disease and adenosine deaminase deficiency. A molecular defect. Academic Press, New York

    Google Scholar 

  4. Mittal KK, Mickey MR, Singal DP, Terasaki PI (1968) Serotyping for homotransplantation. XVIII Refinement of microdroplet lymphocyte cytotoxicity test. Transplantation 6: 913–927

    PubMed  CAS  Google Scholar 

  5. Philippe N, Touraine JL, Renaud H, Evrard A, Betuel H, Monnet P (1980) The bare lymphocyte syndrome. II Clinical course before and after bone marrow transplantation. Blut 41: 202–206

    Google Scholar 

  6. Schuurman RKB, Van Rood JJ, Vossen JM, Schellekens PThA, Felkamp-Vroom ThM, Doyer E, Gmelig-Meyling F, Visser HK (1979) Failure of lymphocyte-membrane HLA-A and B expression in two siblings with combined immunodeficiency. Clin Immunol Immunopathol 14: 418–434

    Article  PubMed  CAS  Google Scholar 

  7. Touraine JL (1979) Human T-lymphocyte differentiation in immunodeficiency diseases and after reconstitution by bone marrow or fetal thymus transplantation. Clin Immunol Immunopathol 12: 228–237

    Article  PubMed  CAS  Google Scholar 

  8. Touraine JL (1979) Heterogeneity and pathophysiology of severe combined immunodeficiency diseases. In: Touraine JL (ed) Bone Marrow Transplantation in Europe. Excerpta Medica. Amsterdam, pp 111–116

    Google Scholar 

  9. Touraine JL, Betuel H, Souillet G, Jeune M (1978) Combined immunodeficiency disease associated with absence of cellsurface HLA-A and B antigens. J Pediatr 93: 47–51

    PubMed  CAS  Google Scholar 

  10. Touraine JL, Touraine F, Hadden JW, Hadden EM, Good R (1976) 5-Bromodeoxyuridine-light inactivation of human lymphocytes stimulated by mitogens and allogeneic cells. Evidence for distinct T-lymphocyte subsets. Int Arch Allergy Appl Immunol 52: 105–117

    PubMed  CAS  Google Scholar 

  11. Zinkernagel RM (1978) The thymus. Its influence on recognition of “self major histocompatibility antigens” by T cells and consequences for reconstitution of immunodeficiency. Springer Semin Immunopathol 1: 405

    Article  Google Scholar 

References

  1. Bergsma D, Good RA, Finstad J, Paul NW (1975) Immunodeficiency in man and animals. Birth Defects: original article series Vol XI. General discussion, p 510, pp. 512–513

  2. Schuurman RKB, Van Rood JJ, Vossen JM, Schellekens PTA, Feltkamp-Vroom TM, Deyer E, Gmelig-Meyling F, Visser HKA (1979) Failure of lymphocyte Membrane HLA-A and-B expression in two siblings with combined immunodeficiency. Clin Immunol Immunopathol 14: 418–434

    Article  PubMed  CAS  Google Scholar 

  3. Touraine JL, Betuel H, Souillet G, Jeune M (1978) Combined immunodeficiency disease associated with absence of cell-surface HLA-A and-B antigens. J Pediatr 93: 47–51

    PubMed  CAS  Google Scholar 

  4. Touraine JL, Betuel H, Philippe N (1980) The bare lymphocyte syndrome (I). Immunological studies before and after bone marrow transplantation. Blut 41: 198–202

    Google Scholar 

References

  1. Fefer A, Buckner CD, Thomas ED et al (1977) Cure of hematologic neoplasia with transplantation of marrow from identical twins. N Engl J Med 297: 146–148

    Article  PubMed  CAS  Google Scholar 

  2. Thomas ED, Storb R, Clift RA et al (1975) Bone-marrow transplantation. N Engl J Med 292: 832–843; 895–902

    Article  PubMed  CAS  Google Scholar 

  3. Thomas ED, Buckner CD, Banaji M et al (1977) One hundred patients with acute leukaemia treated by chemotherapy, total body irradiation, and allogeneic marrow transplantation. Blood 49: 511–533

    PubMed  CAS  Google Scholar 

  4. Thomas ED, Flournoy N, Buckner CD et al (1977) Cure of leukaemia by marrow transplantation. Leuk Res 1: 67–70

    Article  Google Scholar 

  5. Thomas ED, Buckner CD, Fefer A et al (1978) Marrow transplantation in the treatment of acute leukaemia. Ady Cancer Res 27: 269–279

    CAS  Google Scholar 

  6. Powles RL (1976) Pittalls in analysis of survival in clinical trials. Biomedicine 24: 327–328

    PubMed  CAS  Google Scholar 

References

  1. Fefer A, Buckner CD, Thomas ED et al (1977) Cure of haematologic neoplasia with transplantation of marrow from identical twins. N Engl J Med 297: 146

    Article  PubMed  CAS  Google Scholar 

  2. Freireich EJ, Keating MJ, Gehan EA, McCredie KB, Bodey GP, Smith T (1978) Therapy of acute myelogenous leukaemia. Cancer 42: 874

    Article  PubMed  CAS  Google Scholar 

  3. Gale RP for the U.C.L.A. Bone marrow transplantation group (1977) Bone marrow transplantation with intensive combination chemotherapy/radiation therapy (SCARI) in acute leukaemia. Ann Intern Med 86: 155

    Google Scholar 

  4. Graw RG Jr, Lohrmann HP, Bull M et al (1974) Bone marrow transplantation following combination chemotherapy immunosuppression (B.A.C.T.) in patients with acute leukaemia. Transplant Proc 6: 349

    PubMed  Google Scholar 

  5. Guiot HFL, Furth R van (1977) Partial antibiotic decontamination. Br Med J 1: 800

    Article  CAS  PubMed  Google Scholar 

  6. Mattie H, Meer JWM van der, Zwaan FE (eds) (1979) Supportive care in bone marrow insufficiency. Neth J Med 22, No. 4

  7. Powles RL (1976) Pitfalls in analysis of survival in clinical trials. Biomedicine 24: 327

    PubMed  CAS  Google Scholar 

  8. Thomas ED, Storb R, Clift RA et al (1975) Bone marrow transplantation. N Engl J Med 292: 832, 895

    Article  PubMed  CAS  Google Scholar 

  9. Thomas ED, Flournoy N, Buckner CD et al (1977a) Cure of hematologic neoplasia by morrow transplantation. Leuk Res 1: 67

    Article  Google Scholar 

  10. Thomas ED, Buckner CD, Benaji M et al (1977b) One hundred patients with acute leukaemia, treated by chemotherapy, total body irradiation, and allogeneic marrow transplantation. Blood 49: 511

    PubMed  CAS  Google Scholar 

  11. Thomas ED (1978) Marrow transplantation for acute leukaemia. Cancer 42: 895

    Article  PubMed  CAS  Google Scholar 

  12. Thomas ED, Buckner EC, Clift RA et al (1979) Marrow transplantation for acute nonlymphoblastic leukaemia in first remission. N Engl J Med 301: 597

    Article  PubMed  CAS  Google Scholar 

  13. Touraine JL, Triau R, Zwaan FE (eds) (1979) Bone marrow transplantation in Europe. Symposia Foundation Mérieux 2. Excerpta Medica, Amsterdam Oxford-Princeton

    Google Scholar 

  14. Willemze R, Ottolander GJ den, Heering KJ, Brand A, Zwaan FE et al (1977) Behandeling van acute myeloide leukaemie bij volwassenen; een verantwoording over de jaren 1968 t/m 1975. Ned Tijdschr Geneeskd 121: 1843

    PubMed  CAS  Google Scholar 

  15. Zwaan FE, Haak HL, Meer CW van der, Guiot HFL et al (1978) Beenmergtransplantatie en(of) immunosuppressie met anti-thymocyten globuline bij de behandeling van aplastische anaemie. Ned Tijdschr Geneeskd 122: 326

    PubMed  CAS  Google Scholar 

References

  1. Berkman EM, Caplan S, Kim CS (1978) ABO-Incompatible bone marrow transplantation: preparation by plasma exchange and “in vivo” antibody absorption. Transfusion 18: 504–508

    Article  PubMed  CAS  Google Scholar 

  2. Gale RP and the UCLA Bone Marrow Transplant Unit (1979) Current Status of Bone marrow transplantation in acute leukemia. Transplant Proc 11: 1920–1923

    Google Scholar 

  3. Mannoni P, Rodet M, Vernant JP, Brun B, Coquin-Radeau EI, Bracq C, Rochant H, Dreyfus B (1979) Efficiency of prophylactic granulocyte transfusions in preventing infections in acute leukemia. Rev Fr Transfus Immunohematol 22: 503–518

    PubMed  CAS  Google Scholar 

  4. Storb R, Ochs HD, Weiden PL, Thomas ED (1976) Immunologica reactivity in marrow graft recipients. Transplant Proc 8: 637–639

    PubMed  CAS  Google Scholar 

  5. Thomas ED, Storb R, Clift RA, Fefer A, Johnson FL, Neiman PE, Lerner KG, Glucksberg H, Buckner CD (1975) Bone-marrow transplantation. N Engl J Med 292: 832–843, 895–902

    Article  PubMed  CAS  Google Scholar 

  6. Thomas ED, Buckner CD, Banaji M, Clift RA, Fefer A (1977) One hundred patients with acute leukemia treated by chemotherapy, total body irradiation and allogeneic bone marrow transplantation. Blood 49: 511–533

    PubMed  CAS  Google Scholar 

  7. Thomas ED, Buckner CD, Clift RA, Fefer A, Johnson FL, Neiman PE, Sale GE, Sanders JE (1979) Marrow transplantation for acute nonlymphoblastic leukemia in first remission. N Engl J Med 301: 597–599

    Article  PubMed  CAS  Google Scholar 

  8. Witherspoon RP, Storb B, Mickelson EM, Weiden PL, Thomas ED (1979) Association of interstitial pneumonia and diminished in vitro lymphocyte blastogenesis in human marrow graft recipients. Transplantation 28: 412–414

    PubMed  CAS  Google Scholar 

References

  1. Basch RS, Janossy G, Greaves MF (1977) Murine pluripotential stem cells lack Ia antigen. Nature 270: 520–522

    Article  PubMed  CAS  Google Scholar 

  2. Bollum FJ (1975) Antibody to terminal deoxynucleotidyl transferase. Proc Natl Acad Sci USA 72: 4119

    Article  PubMed  CAS  Google Scholar 

  3. Brown G, Greaves MF (1974) Cell surface markers for human T and B lymphocytes. Eur J Immunol 4: 302–310

    PubMed  CAS  Google Scholar 

  4. Cline MJ, Billing R (1977) Antigens expressed by human B lymphocytes on myeloid stem cells. J Exp Med 146: 1143–1145

    Article  PubMed  CAS  Google Scholar 

  5. Crawford DH, Janossy G, Hetherington CM, Francis GE, Edwards AJ, Bousfield B, Prentice HG, Hoffbrand AV (1980) Immunological characterization of haemopoietic cells in the common marmoset, rhesus monkey and man: In Search of a model for human bone marrow transplantation (in prep)

  6. Greaves MF, Brown G, Rapson NT, Lister TA (1975) Antisera to acute lymphoblastic leukaemia cells. Clin Immunol Immunopathol 4: 67–84

    Article  PubMed  CAS  Google Scholar 

  7. Greaves MF, Janossy G (1978) Patterns of gene expression and the cellular origins of human leukaemias. Biochim Biophys Acta 516: 193–230

    PubMed  CAS  Google Scholar 

  8. Hetherington CM, Crawford DH, Crawford T, Janossy G, Prentice HG (1980) Whole body irradiation and bone marrow transplantation in the common marmoset (Callithrix jacchus) (in prep)

  9. Jacobs P, Dubovsky D, Smith S, Randall G, Bracher M (1979) Bone marrow culture in vitro: a technique for analysis and permanent recording of cellular composition. Exp Hematol 7: 177–182

    PubMed  CAS  Google Scholar 

  10. Janossy G, Goldstone AH, Capellaro D, Greaves MF, Kulenkampff J, Pippard M, Welsh K (1977) Differentiation linked expression of P28, 33 (Ia-like) structures on human leukaemic cells. Br J Haematol 37: 391–402

    PubMed  CAS  Google Scholar 

  11. Janossy G, Greaves MF, Sutherland R, Durrant J, Lewis C (1977) Comparative analysis of membrane phenotypes in acute lymphoid leukemia and in lymphoid blast crisis of chronic myeloid leukemia. Leuk Res 1: 289–300

    Article  Google Scholar 

  12. Pike BL, Robinson WA (1970) Human bone marrow colony growth in agar-gel. J Cell Physiol 76: 77–84

    Article  PubMed  CAS  Google Scholar 

  13. Reinherz EL, Schlossman SF (1979) Con A-Inducible suppression of MLC: evidence for mediation by the TH2 + T cell subset in man. J Immunol 122: 1335–1341

    PubMed  CAS  Google Scholar 

  14. Schlossman SF, Chess L, Humphreys RE, Strominger JL (1976) Distribution of Ia-like molecular on the surface of normal and leukaemic human cells. Proc Natl Acad Sci USA 73: 1288

    Article  PubMed  CAS  Google Scholar 

  15. Winchester RJ, Ross GD, Jarowski CI, Wang CY, Halper J, Boxmeyer HE (1977) Expression of Ia-like antigen molecules on human granulocytes during early phases of differentiation. Proc Natl Acad Sci USA 74: 4012–4016

    Article  PubMed  CAS  Google Scholar 

  16. Wislocki GB (1939) Observations on twinning in marmosets. Am J Anat 64: 445–483

    Article  Google Scholar 

References

  1. Aguet M, Andersson LC, Andersson R, Wight E, Binz H, Wigzell H (1978) Induction of specific immune unresponsiveness with purified mixed leukocyte culture-activated T-lymphoblasts as autoimmunogen: II An analysis of the effects at the cellular and serological levels. J Exp Med 147: 50–62

    Article  PubMed  CAS  Google Scholar 

  2. Andersson LC, Binz H, Wigzell H (1976) Specific unresponsiveness to transplantation antigens induced by autoimmunisation with syngeneic, antigen-specific T-lymphoblasts. Nature 264: 778–780

    Article  Google Scholar 

  3. Andersson LC, Aguet M, Wight E, Andersson R, Binz H, Wigzell H (1977) Induction of specific immune unresponsiveness using purified mixed leukocyte culture-activated T-lymphoblasts as autoimmunogen: I Demonstration of general validity as to species and histocompatibility barriers. J Exp Med 146: 1124–1137

    Article  PubMed  CAS  Google Scholar 

  4. Binz H, Wigzell H (1976) Successful induction of specific tolerance to transplantation antigens using autoimmunisation against the recipient's own natural antibodies. Nature 262: 294–295

    Article  PubMed  CAS  Google Scholar 

  5. Binz H, Wigzell H (1978) Induction of specific immune unresponsiveness with purified mixed leukocyte culture-activated T-lymphoblasts as autoimmunogen: III Proof for the existence of autoanti-idiotypic killer T-cells and transfer of suppression to normal syngeneic recipients by T or B lymphocytes. J Exp Med 147: 63–76

    Article  PubMed  CAS  Google Scholar 

  6. Eichmann K (1974) Idiotype suppression. Eur J Immunol 4: 296–302

    PubMed  CAS  Google Scholar 

  7. Jerne NK (1974) Towards a network theory of the immune system. Ann Immunol 125C: 373–389

    CAS  Google Scholar 

  8. Myburgh JA, Smit JA (1978) Auto-anti-idiotypic immunisation and transplantation tolerance. S Afr J Surg 16: 213–214

    Google Scholar 

  9. Rodt HV (1980) EBMT Meeting, Sils-Maria, April 13–16, 1980

  10. Snippe H, Belder M, Willers JMN (1977) Dimethyl dioctadecyl ammonium bromide as adjuvant for delayed hypersensitivity in mice. Immunology 33: 931–936

    PubMed  CAS  Google Scholar 

  11. Yamamura M, Nikbin B, Hobbs JR (1976) Standardisation of the mixed lymphocyte reaction. J Immunol Methods 10: 367–378

    Article  PubMed  CAS  Google Scholar 

References

  1. Dicke KA, Spitzer G, Peters L et al (1979) Autologous bone marrow transplantation in relapsed adult acute leukemia. Lancet I: 514

    Article  Google Scholar 

  2. Netzel B, Rodt H, Lau B et al (1978) Transplantation of syngeneic bone marrow incubated with leukocyte antibodies. II. Cytotoxic activity of anti-cALL globulin on leukemic cells and normal precursor cells in man. Transplantation 26: 157

    PubMed  CAS  Google Scholar 

  3. Rodt H, Netzel B, Thiel E et al (1977) Classification of leukemic cells with T and O-ALL specific antisera. Hematol Blood Transfus 20: 87

    CAS  Google Scholar 

  4. Netzel B, Haas RJ, Janka GE et al (1978) Viability of stem cells (CFU-C) after long term cryopreservation of bone marrow cells from normal adults and children with acute lymphoblastic leukemia in remission. In: Cell separation and cryobiology. FK Schattauer, Stuttgart New York, p 255

    Google Scholar 

  5. Netzel B, Rodt H, Haas RJ et al (1980) The concept of antileukemic, autologous bone marrow transplantation in acute lymphoblastic leukemia. Hematol Blood Transfus 25: 297

    CAS  Google Scholar 

  6. Dicke KA, McCredie KB, Stevens EE et al (1977) Autologous bone marrow transplantation in an adult lymphatic leukemia patient. Transplant Proc 9 (1): 193

    PubMed  CAS  Google Scholar 

  7. Netzel B, Rodt H, Hoffman-Fezer G et al (1978) The effect of crude and differently absorbed anti-human T-cell globulin on granulocytic and erythropoietic colony formation. Exp Hematol 6: 410

    PubMed  CAS  Google Scholar 

  8. Greaves M, Delia D, Janossy G et al (1980) Acute lymphoblastic leukemia associated antigen. IV. Expression on non-leukemic ‘lymphoid’ cells. Leuk Res (in press)

  9. Netzel B, Haas RJ, Rodt H et al (1980) Antileukemic, autologous bone marrow transplantation in childhood acute lymphoblastic leukemia. Eur J Pediatr 133 (2): 185

    Google Scholar 

References

  1. Dupont B, Hansen JA (1978) Donor selection for bone marrow transplantation: The predictive value of HLA-D typing for MLC compatibility between unrelated individuals. Transplant Proc 10: 53–56

    PubMed  CAS  Google Scholar 

  2. Hugh-Jones K (1979) A successful graft from an unrelated donor into an infant with severe combined immune deficiency disease. EMBT Meeting St. Moritz April 1979

  3. Jeannet M, Speck B, Sartorius J (1978) Donor selection for bone marrow transplantation. Predictive value of DR typing for mixed lymphocyte culture compatibility between unrelated individuals. Transplantation 26: 448–449

    Article  PubMed  CAS  Google Scholar 

  4. Kenny AB, Hitzig WH (1979) Bone marrow transplantation for severe combined immunodeficiency disease. Report from 1968 to 1977. Eur J Pediatr 131: 155–177

    Article  PubMed  CAS  Google Scholar 

  5. Keuning JJ, Termijtelen A, Blussé van Oud Alblas A, Gabb B, D'Amaro J, van Rood JJ (1975) LD (MLC) population and family studies in a Dutch population. In: Kissmeyer-Nielsen F et al (eds) Histocompatibility testing 1975. Munksgaard, Copenhagen, p 533

    Google Scholar 

  6. O'Reilly RJ, Dupont B, Pahwa S, Grimes E, Smithwick EM, Pahwa R, Schwartz S, Hansen JA, Siegal FP, Sorrell M, Svejgaard A, Jersild C, Thomsen M, Platz P, L'Espérance P, Good RA (1977) Reconstitution in severe combined immunodeficiency by transplantation of marrow from an unrelated donor. N Engl J Med 297: 1311–1318

    Article  PubMed  Google Scholar 

  7. van Rood JJ, van Leeuwen A, Ploem JS (1976) Simultaneous detection of two cell populations by two-colour fluorescence and application to the recognition of B cell determinants. Nature 262: 795–797

    Article  PubMed  Google Scholar 

  8. van Rood JJ, van Leeuwen A, Goulmy E, Munro A, Termijtelen A, Bradley BA (1978) Recent developments in histocompatibility testing in bone marrow transplantation. In: Baum SJ, Redney GD (eds) Experimental hematology today 1978. Springer, Berlin Heidelberg New York, p 171

    Google Scholar 

  9. van Rood JJ, van Leeuwen A, Goulmy E, Termijtelen A, Bradley BA, Brand A, Eernisse JG (1978) The importance of non-HLA systems and the feasibility to the use of unrelated donors in bone marrow transplantation. Transplant Proc 10: 47–51

    PubMed  Google Scholar 

  10. Stiehm ER, Lawler GJ, Kaplan MS, Greenwald HL, Neerhout RC, Sengar DPS, Terasaki PI (1972) Immunologic reconstitution in severe combined immunodeficiency without bone marrow chromosome chimerism. N Engl J Med 286: 797–803

    Article  PubMed  CAS  Google Scholar 

References

  1. Harris R, Lawler SD, Oliver RTD (1978) The HLA system in acute leukemia and Hodgkin's disease. Br Med Bull 34: 301–304

    PubMed  CAS  Google Scholar 

  2. Lilly F, Pincus T (1973) Genetic control of murine viral leukemogenesis. Adv Cancer Res 17: 231–277

    Article  Google Scholar 

Download references

Authors
  1. Bruno Speck
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Speck, B. Proceedings of the Annual Meeting of the European Foundation for Bone Marrow Transplantation. Blut 41, 151–245 (1980). https://doi.org/10.1007/BF02464145

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF02464145

Keywords

Search

Navigation